Media

Ilya Co-founder Mia Phillipson receives Olof Rudbeck medal for science and innovation

Uppsala University awards the Olof Rudbeck Medal for pioneering work in immune system physiology.

Microbiome Times highlights new program with CXCL17 expressing non-colonising L. reuteri for lung disease

Company Newsletter March 2026

Company Newsletter January 2026

Co-founder Professor Mia Phillipson elected member of the Royal Swedish Academy of Engineering Sciences (IVA)

Nordic Life Science highlights Ilya Pharma's work during World AMR Awareness Week

Contagion Live highlights new publication showing the dual action of ILP100

Healing of skin and mucosal surfaces and killing multi- and severely drug resistant bacterial pathogens.

BEAM Alliance shares data of ILP100 killing multi drug resistant bacteria

Ilya Pharma CEO selected for Eisenhower Fellowship

Mia Phillipson and Evelina Vågesjö receive Hans Wigzell Research Foundation's Scientific Prize of 100 000 USD

ILP100-Oral highlighted in an Editorial by American Journal of Gastrointestinal and Liver Physiology

Ilya Pharma receives Rare Pediatric Disease Designation from US FDA

Nordic Life Science reports on Ilya Pharma's 5 mEUR financing round

CEO interviewed by LifeScience Sweden

ILP100-Topical data highlighted by American Society for Microbiology

Podcast (in Swedish): CEO Evelina Vågesjö gives a company update

Ilya Pharma reports enrolment of first patient in phase 2a trial